Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus 1 Positive”

164 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 164 results

Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Post-approval studies (Phase 4)Study completedNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Testing effectiveness (Phase 2)Ended earlyNCT01601626
What this trial is testing

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 71
Early research (Phase 1)Study completedNCT01894776
What this trial is testing

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc

Who this might be right for
HIV InfectionHIV-1 InfectionMycobacterium Avium Complex (MAC)
Ottawa Hospital Research Institute 15
Not applicableStudy completedNCT00001117
What this trial is testing

Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)UnknownNCT03774108
What this trial is testing

Metformin and Systemic Inflammation in HIV

Who this might be right for
PreDiabetesHIV-1-infection
Hospital Civil de Guadalajara 40
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Not applicableStudy completedNCT01766830
What this trial is testing

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Who this might be right for
Visceral LeishmaniasisHuman African TrypanosomiasisEnteric Fever+9 more
University Hospital, Geneva 1,927
Testing effectiveness (Phase 2)Study completedNCT00530920
What this trial is testing

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 85
Not applicableStudy completedNCT00000890
What this trial is testing

Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableNot Yet RecruitingNCT07390916
What this trial is testing

Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

Who this might be right for
HIV (Human Immunodeficiency Virus)HPVCervical Precancer
Fred Hutchinson Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT00967187
What this trial is testing

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

Who this might be right for
HIV Infections
Myrexis Inc. 32
Post-approval studies (Phase 4)Ended earlyNCT01700790
What this trial is testing

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Who this might be right for
AIDSTuberculosis
University of Miami 9
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT03886701
What this trial is testing

Doravirine, Rifapentine and Isoniazid Interaction

Who this might be right for
Latent TuberculosisHuman Immunodeficiency VirusRifamycins Causing Adverse Effects in Therapeutic Use+1 more
Walter K. Kraft 11
Early research (Phase 1)UnknownNCT03199690
What this trial is testing

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Who this might be right for
HIV-1-infectionTuberculosis
St. Stephens Clinical Research 16
Post-approval studies (Phase 4)Looking for participantsNCT06907056
What this trial is testing

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico

Who this might be right for
HIV Infection
José Antonio Mata Marín 138
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Next Page